HN2002000341A - Composiciones farmaceuticas para el tratamiento de la diabetis mellitus - Google Patents

Composiciones farmaceuticas para el tratamiento de la diabetis mellitus

Info

Publication number
HN2002000341A
HN2002000341A HN2002000341A HN2002000341A HN2002000341A HN 2002000341 A HN2002000341 A HN 2002000341A HN 2002000341 A HN2002000341 A HN 2002000341A HN 2002000341 A HN2002000341 A HN 2002000341A HN 2002000341 A HN2002000341 A HN 2002000341A
Authority
HN
Honduras
Prior art keywords
treatment
pharmaceutical compositions
diabetis mellitus
diabetis
mellitus
Prior art date
Application number
HN2002000341A
Other languages
English (en)
Inventor
Tosetti Alessandro
Guiducci Mauro
Viti Giovanni
Original Assignee
Menarini Int Operations Lu Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11442301&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HN2002000341(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Menarini Int Operations Lu Sa filed Critical Menarini Int Operations Lu Sa
Publication of HN2002000341A publication Critical patent/HN2002000341A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE DESCRIBEN COMPOSICIONES FARMACEUTICAS SUMINISTRABLES POR VIA ORAL EN FORMA DE COMPRIMIDOS PARA EL TRTAMIENTO DE LA DIABETES MELLITIS DE TIPO II, QUE COMPRENDEN GLIBENCLAMIDA Y METFORMINA, O SUS SALES FARMACEUTICAMENTE ACEPTABLES, COMO PRINCIPIOS ACTIVOS, MANTENIDOS EN FORMA SEPARADA ENTRE ELLOS EN EL INTERIOR DE LA MISMA COMPOSICION.
HN2002000341A 2001-11-29 2002-11-29 Composiciones farmaceuticas para el tratamiento de la diabetis mellitus HN2002000341A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001FI000230A ITFI20010230A1 (it) 2001-11-29 2001-11-29 Composizioni farmaceutiche per il trattamento del diabete mellito di tipo ii

Publications (1)

Publication Number Publication Date
HN2002000341A true HN2002000341A (es) 2009-12-07

Family

ID=11442301

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2002000341A HN2002000341A (es) 2001-11-29 2002-11-29 Composiciones farmaceuticas para el tratamiento de la diabetis mellitus

Country Status (39)

Country Link
US (1) US20050053661A1 (es)
EP (1) EP1458364B1 (es)
JP (1) JP4474162B2 (es)
KR (1) KR20040079898A (es)
CN (1) CN1596103B (es)
AR (1) AR037407A1 (es)
AT (1) ATE387190T1 (es)
AU (1) AU2002358061B2 (es)
BR (1) BR0214403A (es)
CA (1) CA2466677A1 (es)
CO (1) CO5590906A2 (es)
CY (1) CY1107966T1 (es)
DE (1) DE60225331T2 (es)
DK (1) DK1458364T3 (es)
EA (1) EA006766B1 (es)
EG (1) EG24124A (es)
ES (1) ES2302862T3 (es)
HN (1) HN2002000341A (es)
HR (1) HRP20040501A2 (es)
HU (1) HUP0402154A3 (es)
IL (1) IL162143A0 (es)
IT (1) ITFI20010230A1 (es)
MA (1) MA27087A1 (es)
MX (1) MXPA04004974A (es)
MY (1) MY141243A (es)
NO (1) NO20042713L (es)
NZ (1) NZ533779A (es)
PA (1) PA8559801A1 (es)
PE (1) PE20030580A1 (es)
PL (1) PL206016B1 (es)
PT (1) PT1458364E (es)
RS (1) RS50937B (es)
SI (1) SI1458364T1 (es)
SV (1) SV2004001415A (es)
TN (1) TNSN04095A1 (es)
UA (1) UA81615C2 (es)
UY (1) UY27549A1 (es)
WO (1) WO2003045355A1 (es)
ZA (1) ZA200404880B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE508738T1 (de) * 2001-01-12 2011-05-15 Sun Pharma Advanced Res Co Ltd System zur beabstandeten abgabe von arzneimitteln
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
EP1617832B1 (en) 2003-04-29 2008-03-12 Orexigen Therapeutics, Inc. Compositions for affecting weight loss
PE20061245A1 (es) * 2005-03-30 2007-01-06 Generex Pharm Inc Composiciones para la transmision transmucosa oral de la metformina
TWI471145B (zh) * 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
DK2089005T3 (da) * 2006-11-09 2010-07-19 Orexigen Therapeutics Inc Lagdelte farmaceutiske formuleringer omfattende et hurtigt opløsende mellemlag
ITMI20062254A1 (it) * 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
WO2009158114A1 (en) 2008-05-30 2009-12-30 Orexigen Therapeutics, Inc. Methods for treating visceral fat conditions
CA2638240C (en) 2008-08-29 2010-02-02 Alexander Macgregor Method of treating dysglycemia and glucose excursions
RU2398572C1 (ru) * 2009-05-18 2010-09-10 Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова Федерального агентства по здравоохранению и социальному развитию" Способ лечения больных сахарным диабетом 2 типа
MX344303B (es) 2010-01-11 2016-12-13 Orexigen Therapeutics Inc Metodos para proveer terapia de perdida de peso en pacientes con depresion mayor.
RU2483717C2 (ru) * 2010-11-22 2013-06-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения диабета (варианты)
US9572784B2 (en) 2011-01-07 2017-02-21 Elcelyx Therapeutics, Inc. Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
US11759441B2 (en) 2011-01-07 2023-09-19 Anji Pharmaceuticals Inc. Biguanide compositions and methods of treating metabolic disorders
US9211263B2 (en) 2012-01-06 2015-12-15 Elcelyx Therapeutics, Inc. Compositions and methods of treating metabolic disorders
US8796338B2 (en) 2011-01-07 2014-08-05 Elcelyx Therapeutics, Inc Biguanide compositions and methods of treating metabolic disorders
US9480663B2 (en) 2011-01-07 2016-11-01 Elcelyx Therapeutics, Inc. Biguanide compositions and methods of treating metabolic disorders
HUE051738T2 (hu) 2011-01-07 2021-03-29 Anji Pharma Us Llc Kemoszenzoros receptorligandum-alapú terápiák
US11974971B2 (en) 2011-01-07 2024-05-07 Anji Pharmaceuticals Inc. Compositions and methods for treating metabolic disorders
EA033067B1 (ru) 2012-01-06 2019-08-30 Элселикс Терапьютикс, Инк. Способ лечения метаболических расстройств у пациента, имеющего противопоказание к назначению бигуанидного соединения
KR20200137035A (ko) 2012-01-06 2020-12-08 앤지 파마 유에스 엘엘씨 바이구아나이드 조성물 및 대사 장애를 치료하는 방법
CN110893181A (zh) 2012-06-06 2020-03-20 纳丙药业有限责任公司 治疗超重和肥胖症的方法
BR112017009521A2 (pt) 2014-11-11 2017-12-19 Shionogi & Co comprimido de múltiplas camadas que contém um fármaco instável à luz
KR101750690B1 (ko) * 2015-10-28 2017-06-27 주식회사 종근당 메트포르민 및 로베글리타존을 포함하는 약제학적 조성물
CN105596339A (zh) * 2015-12-23 2016-05-25 青岛海之源智能技术有限公司 一种二甲双胍阿昔莫司复方组合物及制备方法
SG11202011883RA (en) 2018-05-31 2020-12-30 Hua Medicine Shanghai Ltd Pharmaceutical combination, composition, and combination formulation containing glucokinase activator and ppar receptor activator, and preparation methods and uses thereof
CN110128305A (zh) * 2019-05-10 2019-08-16 天津大学 二甲双胍-甲苯磺丁脲新盐型、其制备方法及医药用途
JP2021120357A (ja) * 2020-01-30 2021-08-19 サンノーバ株式会社 錠剤
GB2599950A (en) * 2020-10-16 2022-04-20 Zentiva Ks Pharmaceutical compositions with low amounts of nitrosamine impurities and methods for producing the same
CN113143940A (zh) * 2020-12-30 2021-07-23 成都恒瑞制药有限公司 一种抗糖尿病药物组合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2347531A1 (de) * 1973-09-21 1975-04-30 Hoechst Ag Arzneizubereitungen zur oralen diabetes-behandlung
IT1276130B1 (it) * 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
EP1063973B1 (en) * 1998-03-19 2016-11-16 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method
ATE250418T1 (de) * 1998-07-15 2003-10-15 Merck Sante Sas Tabletten enthaltend eine kombination von glibenclamid und metformin
US6780432B1 (en) * 2000-05-01 2004-08-24 Aeropharm Technology, Inc. Core formulation
ATE508738T1 (de) * 2001-01-12 2011-05-15 Sun Pharma Advanced Res Co Ltd System zur beabstandeten abgabe von arzneimitteln

Also Published As

Publication number Publication date
EP1458364B1 (en) 2008-02-27
UY27549A1 (es) 2003-06-30
SV2004001415A (es) 2004-05-07
NO20042713L (no) 2004-07-16
DK1458364T3 (da) 2008-06-23
DE60225331D1 (de) 2008-04-10
CO5590906A2 (es) 2005-12-30
MY141243A (en) 2010-03-31
IL162143A0 (en) 2005-11-20
EP1458364A1 (en) 2004-09-22
EA200400664A1 (ru) 2004-10-28
ITFI20010230A1 (it) 2003-05-29
RS50937B (sr) 2010-08-31
RS47304A (sr) 2006-10-27
NZ533779A (en) 2007-02-23
AR037407A1 (es) 2004-11-10
HRP20040501A2 (en) 2004-12-31
PE20030580A1 (es) 2003-09-05
UA81615C2 (ru) 2008-01-25
ZA200404880B (en) 2005-07-29
JP4474162B2 (ja) 2010-06-02
HUP0402154A3 (en) 2008-04-28
AU2002358061B2 (en) 2007-01-11
PT1458364E (pt) 2008-05-26
KR20040079898A (ko) 2004-09-16
US20050053661A1 (en) 2005-03-10
AU2002358061A1 (en) 2003-06-10
ATE387190T1 (de) 2008-03-15
HK1069974A1 (en) 2005-06-10
MXPA04004974A (es) 2004-08-11
TNSN04095A1 (en) 2006-06-01
DE60225331T2 (de) 2009-02-26
BR0214403A (pt) 2004-10-19
PL206016B1 (pl) 2010-06-30
PL369851A1 (en) 2005-05-02
MA27087A1 (fr) 2004-12-20
ES2302862T3 (es) 2008-08-01
WO2003045355A1 (en) 2003-06-05
CN1596103A (zh) 2005-03-16
EA006766B1 (ru) 2006-04-28
CA2466677A1 (en) 2003-06-05
JP2005518360A (ja) 2005-06-23
CN1596103B (zh) 2010-06-16
CY1107966T1 (el) 2013-09-04
HUP0402154A2 (hu) 2005-02-28
SI1458364T1 (sl) 2008-08-31
EG24124A (en) 2008-07-07
PA8559801A1 (es) 2003-06-30

Similar Documents

Publication Publication Date Title
HN2002000341A (es) Composiciones farmaceuticas para el tratamiento de la diabetis mellitus
IL184051A (en) Acetylated GLP-1 compounds, containing and using pharmaceutical preparations
CL2007001918A1 (es) Compuestos derivados heteroarilos sustituidos; metodo para la preparacion de los compuestos; composicion farmaceutica; y uso para el tratamiento del dolor, depresion, enfermedad de alzheimer e hipertension entre otras.
ECSP088329A (es) Nuevos diazaespiroalcanos y su uso para el tratamiento de enfermedades mediadas por ccr8
UY28510A1 (es) Compuestos quimicos
AR056055A1 (es) Complejos cristalinos e hidratos de 1-cloro-4-(beta-d-glucopiranos-1-il)-2-(4-etinil-bencil)-benceno
ECSP055853A (es) Nuevos derivados de fluoroglicosidos heterociclicos, productos farmaceuticos que contienen dichos compuestos, y el uso de los mismos
UY27891A1 (es) Nuevos derivados de glicosido de tiofeno, procedimientos para la preparación de los mismos, medicamentos que contienen estos compuestos, y el uso de los mismos.
CL2009001170A1 (es) Composicion farmaceutica para administracion oral que comprende 5-azacitidina de liberacion inmediata sin recubrimiento enterico; y su uso para el tratamiento de una enfermedad asociada a la proliferacion anormal de celulas, tal como sindrome mielodisplasico, leucemia mielogena aguda y cancer de pulmon, entre otros.
CL2009001059A1 (es) Compuestos derivados de 1,3-oxazin-2-ona-3,6 sustituidos, inhibidores de la actividad de la 11-beta-hidroxiesteroide deshidrogenasa i; composicion farmaceutica que los comprende; utiles en el tratamiento de enfermedades tales como diabetes mellitus, entre otras.
GT200600517A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
AR054347A1 (es) Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion
CL2008002052A1 (es) Compuestos derivados de pirazol, inhibidores de la 11 beta-hidroxi-esteroide-deshidrogenasa; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y uso para la preparacion de medicamentos para el tratamiento de diabetes, obesidad, trastornos de ingestion de comida o dislipidemia
AR028810A1 (es) Derivados de arilpiperazinil-ciclohexil indol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos para el tratamiento de la depresion
CR9667A (es) Derivados de benzamida y usos relacionados con los mismos
DOP2009000165A (es) Derivados de oxindol sustituido, medicamentos que los comprenden y uso de los mismos
UY28098A1 (es) Derivados de anilinopirazol útiles en el tratamiento de la diabetes
ECSP088250A (es) Derivados de pirazol como agentes terapéuticos
UY29245A1 (es) Combinaciones medicas
GT200600161A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos
UY29244A1 (es) Combinaciones medicas
GT200600157A (es) Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo
UY29790A1 (es) Sales de diariloimidazola-4-carboxamidas, composiciones que las contienen, procesos de preparación y aplicaciones
AR058361A1 (es) Composiciones lifolizadas de un compuesto de triazolopirimidina
GT200600130A (es) Tetrahidropiridoazepin-8-onas y compuestos relacionados para el tratamiento de la esquizofrenia